SEMIN ONCOL

Publications

  1. 2022
  2. IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time

    Hoeh, B., Flammia, R. S., Hohenhorst, L., Sorce, G., Panunzio, A., Tappero, S., Tian, Z., Saad, F., Gallucci, M., Briganti, A., Terrone, C., Shariat, S. F., Graefen, M., Tilki, D., Antonelli, A., Kosiba, M., Kluth, L. A., Becker, A., Chun, F. K. H. & Karakiewicz, P. I., 10.2022, In: SEMIN ONCOL. 49, 5, p. 394-399 6 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  3. 1998
  4. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.

    Bokemeyer, C., Harstrick, A., Beyer, J., Metzner, B., Rüther, U., Hartmann, J. T., Holstein, K., Derigs, H. G., de Wit, R., Casper, J., Schöffski, P., Kührer, I., Illiger, H. J., Kempf, B., Reichle, A., Föller, A., Hossfeld, D. K., Fischer, J. T., Berdel, W. E., Gerhartz, H. H., Kirchner, H., Pflüger, K. H., Ostermann, H., Kanz, L. & Schmoll, H. J., 1998, In: SEMIN ONCOL. 25(2 Suppl 4), p. 24-28

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review